文献速递妇产影像泌尿生殖MR

基于MRI的Node-RADS对子宫内膜癌盆腔淋巴结转移的多阅片者诊断效能

Multireader diagnostic performance of MRI-based Node-RADS for pelvic lymph node metastasis in endometrial carcinoma.
PubMed 文献 · Eur Radiol · 2025-10-28

本研究回顾性纳入2017年7月至2024年8月的174例子宫内膜癌患者,评估475枚盆腔淋巴结,由两名阅片者应用MRI-Node-RADS评分,以病理结果为金标准。结果显示评分>2为诊断盆腔淋巴结转移的最佳界值,患者水平AUC 0.93(敏感度91.1%、特异度84.5%),区域水平AUC 0.91(敏感度85.9%、特异度91.8%),阅片者间一致性接近完美。

要点

  • MRI-Node-RADS评分>2为诊断盆腔淋巴结转移的最佳界值,患者水平AUC 0.93。
  • 阅片者间一致性患者水平κw=0.87,8个盆腔区域水平κw=0.94。
  • 闭孔淋巴结最佳指标为「质地任何变化」,非闭孔淋巴结为「边界不规则或不清」。

核心结论

  • MRI-Node-RADS可有效诊断子宫内膜癌盆腔淋巴结转移,评分>2可能被推荐作为诊断的最佳参考值。

研究设计与样本

  • 回顾性研究,纳入2017年7月至2024年8月的174例子宫内膜癌患者,评估475枚盆腔淋巴结(85枚转移、390枚非转移),两名阅片者应用MRI-Node-RADS评分,以病理结果为金标准。

诊断标准与关键数值

  • MRI-Node-RADS评分>2在患者水平AUC 0.93(敏感度91.1%、特异度84.5%),在单个盆腔淋巴结区域分析AUC 0.91(敏感度85.9%、特异度91.8%)。

临床应用与阅片要点

  • 作者认为MRI-Node-RADS评分>2可能被推荐作为诊断子宫内膜癌盆腔淋巴结转移的最佳参考值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the efficacy of the MRI-based Node Reporting and Data System (MRI-Node-RADS) in diagnosing pelvic lymph node metastasis (PLNM) in patients with endometrial carcinoma (EC).

MATERIALS AND METHODS: EC patients were retrospectively enrolled from July 2017 to August 2024. Two readers evaluated pelvic lymph nodes (PLNs) using MRI-Node-RADS. Pathological results served as the gold standard for determining the diagnostic accuracy of the scores. The criteria across size-based subregions were compared, focusing on obturator lymph nodes (Ob LNs) and non-obturator lymph nodes (non-Ob LNs). Inter-reader agreement was assessed using the weighted kappa statistic (κw). The area under the curve (AUC) was calculated to assess the sensitivity and specificity of the MRI-Node-RADS scores.

RESULT: Four hundred seventy-five PLNs were evaluated in 174 EC patients, comprising 85 metastatic and 390 non-metastatic PLNs. The inter-reader agreement was near-perfect at both evaluation levels: patient-level analyses (κw = 0.87) and regional analyses across eight pelvic locations (κw = 0.94). An MRI-Node-RADS score of > 2 demonstrated optimal diagnostic performance, with an AUC of 0.93 (91.1% sensitivity, 84.5% specificity) at the patient level and 0.91 (85.9% sensitivity, 91.8% specificity) when analyzing individual PLN regions. The best performance among individual criteria was "Any change in texture" in Ob LNs and "Border: irregular or ill-defined" in non-Ob LNs.

CONCLUSION: The MRI-Node-RADS effectively diagnoses PLNM, and a score of > 2 may be recommended as the optimal reference value for diagnosing PLNM in EC patients.

KEY POINTS: Question Accurate assessment of PLNM is crucial for patients with EC, yet standardized guidelines for radiological reports are lacking. Findings An MRI-Node-RADS score of > 2 is identified as the optimal cut-off for diagnosing PLNM, with nearly perfect inter-reader agreement. Clinical relevance MRI-Node-RADS demonstrates excellent performance in diagnosing PLN metastases in patients with EC, suggesting that Node-RADS could be used as a reliable tool for clinical staging and personalized therapeutic decision-making.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu G, Wang X, Zhao M, et al. Multireader diagnostic performance of MRI-based Node-RADS for pelvic lymph node metastasis in endometrial carcinoma. Eur Radiol. 2025. PMID: 41148326. doi:10.1007/s00330-025-12056-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。